Comparing Organon P/E Against Its Peers
Compared to the aggregate P/E ratio of the 33.12 in the Pharmaceuticals industry, Organon Inc. has a lower P/E ratio of 4.85. Shareholders might be inclined to think that the stock might perform worse than it's industry peers. It's also possible that the stock is undervalued.
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
